Retham Technologies raises $1.5 million
Retham Technologies, a Milwaukee-based company developing rapid testing for a life-threatening immune reaction to a common blood thinner, has raised $1.5 million.
Retham Technologies, a Milwaukee-based company developing rapid testing for a life-threatening immune reaction to a common blood thinner, has raised $1.5 million.